Evaluation of prevalence of 32 mutation in CCR5 gene in breast cancer patients in Rafsanjan city
(Received 24 August, 2008; Accepted 21 May, 2009)AbstractBackground and purpose: Chemokines and their receptors are expressed in different types of malignancies. CC chemokines MIP-1 (CCL3), MIP-1 (CCL4) and RANTES (CCL5) is believed to be anti-tumor and also aid to the metastasis in tumor microenv...
Main Authors: | Mohammad Kazemi Arababadi, Mohammad Reza Mirzaei, Ebrahim Rezazadeh Zarandi, Gholamhossein Hassanshahi, Mohammad Reza Vatani Baf |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2009-01-01
|
Series: | Journal of Mazandaran University of Medical Sciences |
Subjects: | |
Online Access: | http://www.mazums.ac.ir/index.php?digital_library&do=downloadPdf&sid=754 |
Similar Items
-
The frequency of CCR5 promoter polymorphisms and CCR5 32 mutation in Iranian populations
by: Mohammad Zare-Bidaki, et al.
Published: (2015-04-01) -
The Latitude Wise Prevalence of the CCR5-Δ32-HIV Resistance Allele in India
by: Bhatnagar I, et al.
Published: (2009-01-01) -
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01) -
The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation
by: Hütter Gero, et al.
Published: (2011-10-01) -
Evaluation of CCR5Δ32 Polymorphism in Patients with Systemic Lupus Erythematosus and Healthy Individuals
by: Zahra Heydarifard, et al.
Published: (2018-03-01)